There seem to be a lot of "genetic consulting" services that focus on things like cancer, with a modus operandi of:
- Do targeted gene sequencing (usually on a few tumor suppressor genes related to cancer the customer is at-risk of)
- Analyse the respective data and compile a genetic report outlining risks
The few analyses that I've seen around WGS compared to targeted sequencing claim fairly high accuracy of WGS, including on tumor suppressor genes, sufficient that I wouldn't worry about it, given that TGS will also have some degree of error. So it seems to me like there's little point in using a targeted approach compared to WGS nowadays, given that I can buy a 100x WGS for 1k and some of the targeted tests cost upwards of that.
The other question would be whether the clinics have any "specific" data. I doubt this? I've not heard of a lot of closed-source genetic data, besides maybe that of pharma research companies on a few niche topics. So it seems like a Promethease report could match whatever a specialist would be doing here... or even just searching the variants of concern on clinvar.
Is there any reasons I'm missing why these services still exist? Is it just consumers being misinformed? Or am I glancing over some big problems or benefits?
I guess this might be a bit of a silly question, but hopefully the answers to this will help me elucidate some underlying questions about applied genetics.